DexCom (DXCM)
(Real Time Quote from BATS)
$112.31 USD
+0.18 (0.16%)
Updated Jul 24, 2024 03:00 PM ET
4-Sell of 5 4
D Value A Growth B Momentum C VGM
Brokerage Reports
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 201 - 220 ( 414 total )
Company: DexCom, Inc.
Industry: Medical - Instruments
Diabetes Technology Update: Regulatory Environment for AP Programs Less Onerous; MDT''s 670G and CGM Technology Improve; DXCM Seeks Replacement Claim
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
MDT/UHC Insulin Pump Agreement Could Become A Significant POSITIVE for the Other
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Q1 sales ahead, gross profit light chasm crossing more expensive than thought?
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Topline Beat and Solid Fundamentals Should More Than Offset Temporary Noise; Reit. OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Feltl CGM Project: Historical survey of 2,004 CGM users (2007 - present)
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Diabetes 1Q16 Earnings Preview: Despite Seasonally Soft 1Q, Expecting Healthy Trends Driven By New Product Launches
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
1Q16 MedTech Preview: Stable Trends; Prefer the Oversold Names With Solid Fundamentals
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Q4 Results and G5 Mobile launch impressive; stock still too rich for our blood
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Take Advantage of the Pullback As DXCM''s Growth Outlook Remains Robust; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Survey of Diabetes Educators Very Positive for DXCM''s Growth Outlook; Suggests Recent Concerns Misplaced; Reiterate OUTPERFORM on DXCM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Proprietary Survey of Diabetes Educators Suggests Patients Prefer Tandem''s Insulin Pumps; Reiterate OUTPERFORM on TNDM shares
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Q4 2015 Revenue Preannouncement Above Estimates, Reiterate SELL
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Pre-Announces Solid Topline Beat And Issues Revenue Guidance Ahead of Expectations; Reiterate
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
MedTech 2016 Outlook: Risk/Reward Looks Attractive
Provider: WEDBUSH SECURITIES INC.